From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Can Progesterone Prevent Preterm Birth?

Progesterone shows promise, but it’s uncertain when it is most beneficial.

Progesterone is necessary to maintain pregnancy, in part because it inhibits uterine contractility. Studies in some animal models indicate that progesterone levels fall markedly before onset of labor, and 17 alpha-hydroxyprogesterone acetate (17P) has been shown to reduce the rate of recurrent preterm birth (Journal Watch Jun 24 2003). Two new multisite randomized double-blind trials address the efficacy of progesterone in women at increased risk for preterm labor.

In the first study, 655 women with twin gestations received weekly intramuscular injections of 17P or placebo beginning at 16 to 20 weeks of gestation and ending at 35 weeks. Delivery or fetal death before 35 weeks was not significantly different in the two groups.

In the second study, 413 women with cervical length of 15 mm or less on transvaginal sonography examination at 20 and 25 weeks of gestation received either vaginal progesterone or placebo from 24 to 34 weeks of gestation. Significantly fewer women in the progesterone group than in the placebo group had a spontaneous birth before 34 weeks (19.2% vs. 34.4%; relative risk, 0.56). However, no significant difference was observed in neonatal morbidity.

Comment: We still do not have definitive answers about the utility of progestogens for preventing preterm labor. Further studies are clearly needed to clarify when progestogens may be beneficial, especially because preterm birth is the leading cause of neonatal morbidity and mortality in the U.S. A review article in the same issue summarizes the wide range of known contributing factors that underlie the causes of preterm labor.

Robert W. Rebar, MD

Published in Journal Watch General Medicine August 1, 2007

Citation(s):

Rouse DJ et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007 Aug 2; 357:454-61.

Fonseca EB et al. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007 Aug 2; 357:462-9.

Thornton JG. Progesterone and preterm labor — Still no definite answers. N Engl J Med 2007 Aug 2; 357:499-501.

Simhan HN and Caritis SN. Prevention of preterm delivery. N Engl J Med 2007 Aug 2; 357:477-87.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Other Perspectives

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2007. Massachusetts Medical Society. All rights reserved.